Is $AMBS Coiling Up for a Breakout? Amarantus
Post# of 103003
Amarantus Bioscience Holdings, Inc. could be an interesting play to take a closer look at right now. The company is moving closer to marketable assets in orphan-drug designated therapy research, and shares appear to be hanging around at extremely cheap levels, especially given the latest press on the name. https://www.journaltranscript.com/2018/06/is-...a-breakout